UAMY Thesis Assessment
United States Antimony Corporation
UAMY's market price of $10.23 appears to be above the fundamental value indicated by this analysis.
At approximately $1.34B market cap on ~$40-43M revenue guidance ($10.23 stock price implying ~32x revenue), the prediction ensemble reveals significant execution gaps. Only 38% probability of Q1 2026 revenue exceeding $25M (the pace needed for $125M annually), a near coin-flip 52% on antimony prices staying above $20/lb, and 55% on the Montana expansion completing. The DISCONNECTED narrative-reality gap from the meta-synthesis -- pricing commodity-driven revenue as if it were structural growth -- appears confirmed by the ensemble.
What the Markets Suggest
United States Antimony presents the starkest narrative-reality gap in this prediction ensemble. The $1.34B market cap on $40-43M in revenue guidance (32x revenue) is built on three pillars: sole US antimony producer status, the 267% antimony price surge, and the $125M FY2026 revenue guidance. The ensemble systematically questions each pillar.
The most damaging prediction is the 38% probability of Q1 2026 revenue exceeding $25M -- the minimum quarterly pace needed to validate the $125M annual guidance. This suggests the market is pricing in a revenue trajectory that the ensemble considers unlikely. Meanwhile, management is expected to maintain the aggressive $125M guidance (70% probability), creating a widening gap between stated targets and achievable results.
The commodity dependence is exposed by the 52% antimony price sustainability probability. Revenue growth has been overwhelmingly price-driven (267% antimony price increase vs. modest volume growth), and the ensemble assigns nearly equal probability to price reversion. If antimony normalizes below $20/lb while the Montana expansion experiences any delay (45% probability of missing Q1 timeline), the revenue trajectory collapses from both directions simultaneously.
The competitive moat, while genuine today, has a visible expiration date. The 58% probability of Perpetua Resources beginning Stibnite construction before mid-2027 suggests the window of US antimony exclusivity narrows within 18-24 months. The market appears to price permanence into what the analysis identifies as a time-limited advantage.
The current price of $10.23 appears significantly above the fundamental value supported by the prediction ensemble. The analysis indicates that the market prices in a growth scenario -- sustained commodity prices, flawless Montana expansion, and revenue tripling -- that the ensemble assigns relatively low joint probability.
Market Contributions6 markets
The first credibility test at 62% probability. The ensemble leans toward guidance being met, which would be a genuine milestone for a company that had never exceeded $15M in annual revenue before 2025. However, this is largely price-driven, not volume-driven, which limits the signal quality.
At 70% probability with the highest agreement (0.82), the ensemble expects management to maintain aggressive guidance. This is informative about management behavior rather than business fundamentals -- maintaining guidance preserves narrative momentum regardless of whether execution supports it.
The most critical execution test. At only 38% probability, the ensemble strongly doubts that Q1 2026 revenue will be on pace for $125M annually. This is the strongest signal that the market narrative outpaces the operational reality. Below $25M in Q1 would validate the DISCONNECTED assessment.
The 400% capacity expansion at 55% probability reflects moderate execution risk. This is the prerequisite for the volume growth that could decouple revenue from commodity pricing. A delay cascades through all revenue projections and validates the STRETCHED capital deployment assessment.
A near coin-flip at 52% with the second-lowest agreement. The revenue thesis is built on sustained high antimony prices following the 267% increase. The ensemble assigns nearly equal probability to price reversion, which would compress revenue regardless of volume execution.
The competitive moat erosion timeline. At 58% probability with the lowest agreement (0.65), the ensemble leans toward Perpetua beginning construction, which would narrow UAMY's window of US antimony exclusivity from approximately 2027-2028. The CONDITIONAL competitive position has a definite expiration horizon.
Balancing Factors
Critical minerals policy support is bipartisan and structural, with DLA contracts providing a revenue floor regardless of spot pricing
The sole US antimony producer position has genuine strategic value in the current geopolitical environment with China export restrictions
FY2025 revenue guidance hit at 62% probability would represent a genuine operational milestone, demonstrating scalability from a $15M historical base
Near-zero debt and adequate cash position provides a financial cushion for execution delays
The Montana expansion, if successful, would represent a step-function change in production capacity that could decouple revenue from pricing
Key Uncertainties
Whether the 267% antimony price increase is structural (driven by permanent supply restrictions) or cyclical (driven by temporary hoarding and speculation)
The true timeline for Montana expansion completion and ramp to full capacity
Whether the DLA contract provides an adequate revenue floor if spot antimony prices normalize
The pace and scale of Perpetua Resources' Stibnite project as a competitive threat
Critical minerals policy tailwinds are bipartisan and structural. A successful Montana expansion combined with sustained antimony pricing could validate the growth trajectory, and the sole-source US position has genuine strategic value.
Confidence note: Model agreement ranges from 0.65 to 0.82 across six markets. The highest agreement (0.82) is on the FY2026 guidance maintenance market, reflecting conviction about management's near-term messaging. The lower agreement on commodity pricing (0.68) and Perpetua competition (0.65) reflects genuine uncertainty about exogenous factors.
This assessment synthesizes probabilistic forecasts from an AI model ensemble for educational and informational purposes only. Model outputs may contain errors, hallucinations, or data lag. It does not constitute financial advice, a recommendation to buy or sell securities, or a guarantee of future outcomes. Past model performance does not predict future accuracy. Investors should conduct their own research and consult qualified financial advisors before making investment decisions.